OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ

Dilek Yıldırım; Gülbeyaz Can

OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ

Abstract

Opioidler ağrı tedavisinde sık kullanılmaktadır. Opioidlerin analjezik etkisinin yanında bazı yan etkileri de vardır. En yaygın görülen ve hastalar tarafından tanımlanan en rahatsız edici yan etkisi konstipasyondur. Hastaların yaşam kalitesini ve tedaviye uyumunu olumsuz yönde etkileyen konstipasyon, sağlık bakım maliyetlerini arttırmakta, hastanede kalış süresini uzatmakta, hastane başvurularını arttırmakta, tedavi dozlarının atlanmasına, azaltılmasına hatta tedavinin sonlanmasına neden olabilmektedir. Konstipasyon yönetiminde laksatif, lavman, opioid reseptör antagonistleri gibi farmakalojik yaklaşımlar, hasta eğitimi, sıvı ve lif alımını arttırma, egzersiz, abdominal masaj gibi nonfarmakolojik yaklaşımlar önerilmektedir. Ancak literatürde opioid ilişkili konstipasyon yönetiminde etkili bir bakım protokolü tanımlanamamıştır. Literatür verileri ışığında, opioid ilaç tedavisi olan hastalar mutlaka rutin olarak konstipasyon açısından değerlendirilmeli ve opioid ilişkili konstipasyon yönetimine yönelik klinik protokoller oluşturulmalıdır. Sağlık bakım ekibi opioid ilişkili konstipasyon ve yönetimi konusunda bilgilendirilmelidir. Opioid ilişkili konstipasyon yönetiminde yer alan yaklaşımların etkinliğini değerlendirecek randomize kontrollü çalışmalara gereksinim vardır. Bu derleme, sağlık ekibinin opioid ilişkili konstipasyona yönelik bilgi düzeylerinin ve farkındalığının arttırılması amacıyla yapılmıştır.

Keywords

Ağrı tedavisi,Opioidler,Opioid ilişkili konstipasyon,Konstipasyon yönetim

References

1. Gaertner J, Siemens W, Camilleri M, et al. Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review. J Clin Gastroenterol. 2015;49:9-16.
2. Sridharan K, Sivaramakrishnan G. Drugs for treating opioid-induced constipation: A mixed treatment comparison network meta-analysis of randomized controlled clinical trials. J Pain Symptom Manage. 2018;55(2):468-479.
3. Prichard D, Bharucha A. Management of opioid-induced constipation for people in palliative care. Int J Palliat Nurs. 2015;21(6):272-280.
4. Olufade T, Kong AM, Princic N, et al. Comparing healthcare utilization and costs among medicaid-ınsured patients with chronic noncancer pain with and without opioid-ınduced constipation: a retrospective analysis. Am Health Drug Benefits. 2017;10(2):79-86.
5. Boland JW, Boland EG. Pharmacological therapies for opioid induced constipation in adults with cancer. BMJ. 2017;2;358:j3313.
6. Webster L, Chey WD, Tack J, Lappalainen J, Diva U, Sostek M. Randomised clinical trial: the long term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Aliment Pharmacol Ther. 2014;40(7):771-9.
7. Camilleri M, Drossman DA, Becker G, Webster LR, Davies AN, Mawe GM. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil. 2014;26(10):1386-95.
8. Coyne KS, Margolis MK, Yeomans K, et al. Opioid-induced constipation among patients with chronic noncancer pain in the united states, canada,germany, and the united kingdom: laxative use, response, and symptom burden over time. Pain Med. 2014;16(8):1551-65.

9. Nelson AD, Camilleri M. Opioid-induced constipation: Advances and clinical guidance. Ther. Adv. Chronic Dis. 2016;7(2):121-34.
10. Kumar L, Barker C, Emmanuel A. Opioid-induced constipation: Pathophysiology, clinical consequences and management. Gastroenterol Res. Pract. 2014;2014:141737.
11. Panchal SJ, Müller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007;61(7):1181-7.
12. Yılmaz B: Gastrointestinal fizyoloji, “Çavuşoğlu H, Çağlayan Yeğen B (eds): Tıbbi Fizyoloji Guyton & Hall” kitabında, s.771-790, Nobel Matbaacılık, İstanbul (2007).
13. Ducrotté P, Milce J, Soufflet C, Fabry C. Prevalence and clinical features of opioid-induced constipation in the general population: A French study of 15,000 individuals. United European Gastroenterol J. 2017;5(4):588-600.
14. Chokhavatia S, John ES, Bridgeman MB, Dixit D. Constipation in elderly patients with noncancer pain: focus on opioid-induced constipation. Drugs Aging. 2016;33(8):557-74.
15. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372–80.
16. Coyne, KS, LoCasale RJ, Datto CJ, Sexton CC, Yeomans K, Tack J. Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany and the UK: Descriptive analysis of baseline patient-reported outcomes and retrospective chart review. Clinicoecon Outcomes Res. 2014;23;6:269-81.
17. Khademi H, Kamangar F, Brennan P, Malekzadeh R. Opioid therapy and its side effects: A Review. Arch Iran Med. 2016;19(12):870-876.
18. Drewes AM, Munkholm P, Simrén M, et al. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-recommendations ofthe nordic working group. Scand J Pain. 2016;11:111–22.
19. Boswell K, Kwong WJ, Kavanagh S. Burden of opioid-associated gastrointestinalside effects from clinical and economic perspectives: a systematic literaturereview. J Opioid Manag. 2010;6:269-89.
20. LoCasale RJ, Datto C, Margolis MK, Coyne KS. Satisfaction with therapy among patients with chronic noncancer pain with opioid-induced constipation. J Manag Care Spec Pharm. 2016;22(3):246-53.
21. McCarberg BH. Overview and treatment of opioid-induced constipation. Postgrad Med. 2013;125(4):7-17.
22. Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R. The preva-lence, severity, and impact of opioid-induced bowel dysfunction: results of US and European Patient Survey (PROBE 1). Pain Med. 2009;10:35-42.
23. Søndergaard J, Christensen HN, Ibsenc R, Jarbøl DE, Kjellbergd J. Healthcare resource use and costs of opioid-induced constipation among non-cancer and cancer patients on opioid therapy: A nationwide register-based cohort study in Denmark. Scandinavian Journal of Pain. 2017;15:83-90.
24. Argoff CE, Brennan MJ, Camilleri M, et al. Consensus recommendations on ınitiating prescription therapies for opioid induced constipation. Pain Med. 2015;16(12):2324-37.
25. Nilsson M, Poulsen JL, Brock C, et al. Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI. Eur J Gastroenterol Hepatol. 2016;28(5):514-24.
26. Bengi G, Yalçın M, Akpınar H. Kronik kontipasyona güncel yaklaşım. Güncel Gastroenteroloji. 2014;18(1):72-88.
27. Weber C. Opioid-induced constipation in chronic noncancer pain. Curr Opin Endocrinol Diabetes Obes. 2016;23(1):11-7.
28. Brenner DM, Stern E, Cash BD. Opioid-related constipation in patients with non-cancer pain syndromes: a review of evidence-based therapies and justification for a change in nomenclature. Curr Gastroenterol Rep. 2017;19(3):12.
29. Ford AC, Brenner DM, Schoenfeld PS. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and metaanalysis. Am J Gastroenterol. 2013;108:1566–1574.
30. Webster L, Chey WD, Tack J, Lappalainen J, Diva U, Sostek M. Randomised clinical trial: the long term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Aliment Pharmacol Ther. 2014;40(7):771-9.
31. Kyle G. Managing constipation in adult patients. Nurse Prescribing. 2011;9(10):482-90.
32. Kaya H: Bağırsak boşaltımı ve gastrik entübasyon. “Aştı TA, Karadağ A (eds): Klinik Uygulama Becerileri ve Yöntemleri,” kitabında s.1116-1145, Nobel Kitabevi, Adana (2011).33. Özkütük, N: Bağırsak boşaltımı. “Uysal N, Çakırcalı E (eds): Hemşirelik Esasları İnsan Sağlığı ve Fonksiyonları, Yedinci Baskıdan Çeviri” kitabında s.1069-1097, Palme Yayıncılık, Ankara (2015).
34. Yu CT, Ko NY. Evidence-based nursing care for cancer patients with opioid-induced constipation. Hu Li Za Zhi, 2010;57(4):100-5.
35. Dağlı Ü: Konstipasyon. “Mas R, Işık T, Karan A (eds): Geriatri” kitabında s. 900-909, (2008).
36. Ducas L, Willet WC, Giovannucci EL. Association between physical activity, fiber intake and other lifestyle variables and constipation in a study of women. American Journal Of Gastroenterologyl, 2003;98:1760-1766.
37. Kaya N, Turan N: Hareket ve egzersiz.”Aştı TA, Karadağ A (eds): Hemşirelik Esasları Hemşirelik Bilimi ve Sanatı” s.231-389, Akademi Basın ve Yayınılık, İstanbul (2012).
38. Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005;129:86-97.
39. Rao SS, Seaton K, Miller M, Brown K, Nygaard I, Stumbo P, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol. 2007;5:331-8.
40. Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol. 2004;38:475-83.
41. Lamas K, Lindholm L, Stenlund H, Engstrom B, Jacobsson C. Effects of abdominal massage in management of constipation-a randomized controlled trial. International Journal of Nursing Studies. 2009;46(6):759-67.
42. Sinclair M. The Use of abdominal massage to treat chronic constipation. Journal of Bodywork & Movement Therapies. 2010;15(4):436-46.
43. Turan N, Atabek Aştı T. Konstipasyon yönetiminde abdominal masajın önemi. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi. 2015;18(2):148-154.
44. McClurg D, Hagen S, Hawkins S, Lowe-Strong A. Abdominal massage for the alleviation of constipation symptoms ın people with multiple sclerosis: A Randomized Controlled Feasibility Study. Multiple Sclerosis Journal. 2011;17(2):223-233.
45. Kassolik K, Andrzejewski W, Wilk I, et al. The effectiveness of massage based on the tensegrity principle compared with classical abdominal massage performed on patients with constipation. Archives of Gerontology and Geriatrics. 2015;61(2):202-211.
46. Hanai A, Ishiguro H, Sozu T, et al. Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial. Breast Cancer Res Treat. 2016;155(1):99-107.
47. Ozisler Z, Koklu K, Ozel S, Unsal-Delialioglu S. Outcomes of bowel program ın spinal cord injury patients with neurogenic bowel dysfunction. Neural Regen Res. 2015;10(7):1153-1158.
48. Turan N, Atabek Aştı T. The effect of abdominal massage on constipation and quality of life. Gastroenterology Nursing. 2016;39(1):48-59.
49. McClurg D, Hagen S, Jamieson K, Dickinson L, Paul L, Cunnington A. abdominal massage for the alleviation of symptoms of constipation in people with parkinson's: A randomised controlled pilot study. Age and Ageing. 2016;45(2):299-303.

Details

Primary Language

Turkish

Subjects

-

Journal Section

Review

Authors

Dilek Yıldırım ^*
Türkiye

Gülbeyaz Can
Türkiye

Publication Date

April 30, 2019

Submission Date

October 25, 2018

Acceptance Date

January 21, 2019

Published in Issue

Year 2019 Volume: 8 Number: 1

IZ

https://izlik.org/JA65NP68YJ

Cite

RIS / Bibtex

APA

Yıldırım, D., & Can, G. (2019). OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ. Balıkesir Sağlık Bilimleri Dergisi, 8(1), 27-32. https://izlik.org/JA65NP68YJ

AMA

1.Yıldırım D, Can G. OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ. BAUN Health Sci J. 2019;8(1):27-32. https://izlik.org/JA65NP68YJ

Chicago

Yıldırım, Dilek, and Gülbeyaz Can. 2019. “OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ”. Balıkesir Sağlık Bilimleri Dergisi 8 (1): 27-32. https://izlik.org/JA65NP68YJ.

EndNote

Yıldırım D, Can G (April 1, 2019) OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ. Balıkesir Sağlık Bilimleri Dergisi 8 1 27–32.

IEEE

[1]D. Yıldırım and G. Can, “OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ”, BAUN Health Sci J, vol. 8, no. 1, pp. 27–32, Apr. 2019, [Online]. Available: https://izlik.org/JA65NP68YJ

ISNAD

Yıldırım, Dilek - Can, Gülbeyaz. “OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ”. Balıkesir Sağlık Bilimleri Dergisi 8/1 (April 1, 2019): 27-32. https://izlik.org/JA65NP68YJ.

JAMA

1.Yıldırım D, Can G. OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ. BAUN Health Sci J. 2019;8:27–32.

MLA

Yıldırım, Dilek, and Gülbeyaz Can. “OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ”. Balıkesir Sağlık Bilimleri Dergisi, vol. 8, no. 1, Apr. 2019, pp. 27-32, https://izlik.org/JA65NP68YJ.

Vancouver

1.Dilek Yıldırım, Gülbeyaz Can. OPİOİD İLAÇ KULLANAN HASTALARDA GELİŞEN KONSTİPASYONUN YÖNETİMİ. BAUN Health Sci J [Internet]. 2019 Apr. 1;8(1):27-32. Available from: https://izlik.org/JA65NP68YJ